O impacto da COVID-19 na população idosa com doença pulmonar crônica não transmissível

Autores

DOI:

https://doi.org/10.33233/fb.v23i1.4916

Palavras-chave:

COVID-19; infecção por SARS-CoV2; idoso; doença pulmonar obstrutiva crônica; doenças não transmissíveis

Resumo

Introdução: Envelhecer resulta em transformações biológicas que afetam os indivíduos de maneira heterogênea. A maioria dos sistemas orgânicos experimenta redução em suas funções motoras e cognitivas, interferindo na capacidade de adaptação frente a agentes estressores. Na pneumonia pelo SARS-CoV2, evidenciaram-se implicações da função pulmonar em idosos com doenças pulmonares crônicas. Objetivo: Investigar as evidências científicas sobre implicações clínicas da COVID-19 em indivíduos idosos com doença pulmonar crônica não transmissível. Métodos: revisão integrativa realizada em novembro de 2020 nas bases de dados CINAHL (Cumulative Index to Nursing and Allied Health Literature), Embase, Scopus, Medline/Pubmed (via National Library of Medicine) e Web of Science, utilizando-se os descritores “COVID-19”, “SARS-CoV2 infection”, “aged”, “chronic pulmonar obstructive disease”, “non-communicable diseases” e operadores booleanos AND e OR. Foram incluídos textos científicos originais, a exemplo de artigos disponibilizados na íntegra, sobre a COVID-19 em idosos com Doenças Respiratórias Crônicas Não Transmissíveis. Resultados: Idosos com comorbidades estão propensos a complicações durante a infecção por COVID-19, com altas taxas de mortalidade e alterações tomográficas atípicas. Conclusão: A forma grave da COVID-19 e a elevada mortalidade em idosos podem ser atribuídas à alta comorbidade, prevalência de demência e síndromes geriátricas.

Biografia do Autor

Carlos Eduardo Porto da Silva, UFPB

Universidade Federal da Paraíba, João Pessoa, PB, Brasil

Cícera Patrícia Daniel Montenegro, UFPB

Universidade Federal da Paraíba, João Pessoa, PB, Brasil

Fabiana Cristina Taubert de Freitas-Swerts, UNIP

Professora na Universidade Paulista (UNIP), Ribeirão Preto, SP, Brasil

Maria Lúcia do Carmo Cruz Robazzi, USP

Professora da Escola de Enfermagem de Ribeirão Preto da Universidade de São Paulo, Ribeirão Preto, SP, Brasil

Maria Adelaide Silva Paredes Moreira, UFPB

Professora adjunta da Universidade Federal da Paraíba, João Pessoa, PB, Brasil

Referências

Shahid Z, Kalayanamitra R, McClafferty B, Kepko D, Ramgobin D, Patel R, et al. COVID-19 and older adults: what we know. J Am Geriatr Soc 2020;68(5):926-9. doi: 10.1111/jgs.16472

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Mil Med Res 2020;7(1):1-10. doi: 10.1186/s40779-020-00240-0

Brasil. Ministério da Saúde. Secretarias Estaduais de Saúde. COVID-19 no Brasil [Internet]. Brasília, DF: Ministério da Saúde; 2020. [cited 2021 Mar 18]. Available from: https://infoms.saude.gov.br/extensions/covid-19_html/covid-19_html.html

Gao S, Jiang F, Jin W, Shi Y, Yang L, Xia Y, et al. Risk factors influencing the prognosis of elderly patients infected with COVID-19: a clinical retrospective study in Wuhan, China. Aging (Albany NY) 2020;11:12(13):12504-16. doi: 10.18632/aging.103631

Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S, et al. Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med 2020;180(7):934-43. doi: 10.1001/jamainternmed.2020.0994

Mueller AL, McNamara MS, Sinclair DA. Why does COVID-19 disproportionately affect older people? Aging (Albany NY) 2020;12(10):9959-81. doi: 10.18632/aging.103344

Mo X, Jian W, Su Z, Chen M, Peng H, Peng P, et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur Respir J 2020;55(6):1-4. doi: 10.1183/13993003.01217-2020

Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of suspected coronavirus disease 2019 in two emergency departments outside of Hubei, China. J Med Virol 2020;92(9):1525-32. doi: 10.1002/jmv.25763

Arentz M, Yim E, Klaff L, Lokhandwala S, Riedo FX, Chong M, et al. Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State. JAMA 2020;323(16):1612-4. doi: 10.1001/jama.2020.4326

Kiekens C, Boldrini P, Andreoli A, Avesani R, Gamna F, Grandi M, et al. Rehabilitation and respiratory management in the acute and early post-acute phase. “Instant paper from the field” on rehabilitation answers to the COVID-19 emergency. Eur J Phys Rehabil Med 2020;56(3):323-6. doi: 10.23736/S1973-9087.20.06305-4

Guerra S, Carsin AE, Keidel D, Sunyer J, Leynaert B, Janson C, et al. Health-related quality of life and risk factors associated with spirometric restriction. Eur Respir J 2017;49(5):1-11. doi: 10.1183/13993003.02096-2016

Souza MT, Silva M, Carvalho R. Revisão integrativa: o que é e como fazer. Einstein (São Paulo) 2010;8(1Pt 1):102-6. doi: 10.1590/s1679-45082010rw1134

Costa LOP, Maher CG, Lopes AD, Noronha MA de, Costa LCM. Como escrever de forma transparente artigos científicos relevantes para a prática da Fisioterapia. Rev Bras Fisioter (São Carlos) 2011;15(4):267-71. doi: 10.1590/S1413-35552011005000009

Dang JZ, Zhu GY, Yang YJ, Zheng F. Clinical characteristics of coronavirus disease 2019 in patients aged 80 years and older. J Integr Med 2020;18(5):395-400. doi: 10.1016/j.joim.2020.07.002

Wang L, He W, Yu X, Hu D, Bao M, Liu H, et al. Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up. J Infect 2020;80(6):639-45. doi: 10.1016/j.jinf.2020.03.019

Rui L, Sirui L, Xuebei D, Xujun Y, Yanggan W. Clinical observations in very elderly patients with COVID-19 in Wuhan. Geriatr Gerontol Int 2020;20(7):709-14. doi: 10.1111/ggi.13974

Li P, Chen L, Liu Z, Pan J, Zhou D, Wang H, et al. Clinical features and short-term outcomes of elderly patients with COVID-19. Int J Infect Dis 2020;97:245-50. doi: 10.1016/j.ijid.2020.05.107

Guo T, Shen Q, Guo W, He W, Li J, Zhang Y, et al. Clinical characteristics of elderly patients with COVID-19 in Hunan province, China: a multicenter, retrospective study. Gerontol 2020;66(5):467-75. https:/doi.org/10.1159/000508734

Lian J, Jin X, Hao S, Cai H, Zhang S, Zheng L, et al. Analysis of epidemiological and clinical features in older patients with coronavirus disease 2019 (COVID-19) outside Wuhan. Clin Infect Dis 2020;71(15):740-7. doi: 10.1093/cid/ciaa242

Azarpazhooh MR, Morovatdar N, Avan A, Phan TG, Divani AA, Yassi N, et al. COVID-19 pandemic and burden of non-communicable diseases: an ecological study on data of 185 countries. J Stroke Cerebrovasc Dis 2020;29(9):105089. doi: 10.1016/j.jstrokecerebrovasdis.2020.105089

Wyper GMA, Assunção RMA, Cuschieri S, Devleesschauwer B, Fletcher E, Haagsma JA, et al. Population vulnerability to COVID-19 in Europe: a burden of disease analysis. Arch Public Health 2020;78(47):1-8. doi: 10.1186/s13690-020-00433-y

Dai SP, Zhao X, Wu JH. Effects of comorbidities on the elderly patients with COVID-19: clinical characteristics of elderly patients infected with COVID-19 from Sichuan, China. J Nutr Health Aging 2020;25(1):18-24. doi: 10.1007/s12603-020-1486-1

Becerra-Muñoz VM, Núñez-Gil IJ, Eid CM, Aguado MG, Romero R, Huang J, et al. Clinical profile and predictors of in-hospital mortality among older patients hospitalised for COVID-19. Age Ageing 2020;50(2):326-34. doi: 10.1093/ageing/afaa258

Deutsche Welle Coronavírus expõe vulnerabilidade de idosos na Europa. Germany: DW; 2020 Mar 24 [Internet]. [cited 2022 Jan 2022] Available from: https://www.dw.com/pt-br/coronav%C3%ADrus-exp%C3%B5e-vulnerabilidade-de-idosos-na-europa/a-52897626

Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med 2020;8(9):853-62. doi: 10.1016/S2213-2600(20)30316-7

Gold JAW, Wong KK, Szablewski CM, Patel PR, Rossow J, Sila J, et al. Characteristics and clinical outcomes of adult patients hospitalized with COVID-19 – Georgia, March 2020. MMWR 2020;69(18):545-50. doi: 10.15585/mmwr.mm6918e1

Wortham JM, Lee JT, Althomsons S, Latash J, Davidson A, Guerra K, et al. Characteristics of persons who died with COVID-19. MMWR 2020;69(28):923-29. doi: 10.15585/mmwr.mm6928e1

Haase N, Plovsing R, Christensen S, Poulsen LM, Brøchner AC, Rasmussen BS, et al. Characteristics, interventions, and longer-term outcomes of COVID-19 ICU patients in Denmark – a nationwide, observational study. Acta Anaesthesiol Scand 2021;65(1):68-75. doi: 10.1111/aas.13701

Palmieri L, Vanacore N, Donfrancesco C, Lo Noce C, Canevelli M, Punzo O, et al. Clinical characteristics of hospitalized individuals dying with COVID-19 by age group in Italy. J Gerontol A Biol Sci Med Sci 2020;75(9):1796-1800. doi: 10.1093/gerona/glaa146

Zou L, Dai L, Zhang Y, Fu W, Gao Y, Zhang Z, et al. Clinical characteristics and risk factors for disease severity and death in patients with coronavirus disease 2019 in Wuhan, China. Front Med 2020;7:532. doi: 10.3389/fmed.2020.00532

Shi Q, Zhang X, Jiang F, Zhang X, Hu N, Bimu C, et al. Clinical characteristics and risk factors for mortality of COVID-19 patients with diabetes in Wuhan, China: a two-center, retrospective study. Diabetes Care 2020;43(7):1382-91. doi: 10.2337/dc20-0598

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA 20207;323(11):1061-9. doi: 10.1001/jama.2020.1585

Niquini RP, Lana RM, Pacheco AG, Cruz OG, Coelho FC, Carvalho LM, et al. SRAG por COVID-19 no Brasil: descrição e comparação de características demográficas e comorbidades com SRAG por influenza e com a população geral. [Description and comparison of demographic characteristics and comorbidities in SARI from COVID-19, SARI from influenza, and the Brazilian general population]. Cad Saúde Pública 2020;36(7):1-12. doi: 10.1590/0102-311x00149420

Navaratnarajah A, Jackson S. The physiology of ageing. Medicine 2017;45(1):6-10. doi: 10.1016/j.mpmed.2016.10.008

Mesquita AF, Silva EC, Eickemberg M, Roriz AKC, Barreto-Medeiros JM, Ramos LB. Factors associated with sarcopenia in institutionalized elderly. Nutr Hosp 2017;34(2): 345-51. doi: 10.20960/nh.427

Mijnarends DM, Koster A, Schols JM, Meijers JMGA, Halfens RJG, Gudnason V, et al. Physical activity and incidence of sarcopenia: the population-based AGES – Reykjavik Study. Age Ageing 2016;45(5):614-20. doi: 10.1093/ageing/afw090

Brandenberger C, Mühlfeld C. Mechanisms of lung aging. Cell Tissue Res 2016;367(3):469-80. doi: 10.1007/s00441-016-2511-x

Elliott JE, Greising SM, Mantilla CB, Sieck GC. Functional impact of sarcopenia in respiratory muscles. Respir Physiol Neurobiol 2016;226(1):137-46. doi: 10.1016/j.resp.2015.10.001

López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. The hallmarks of aging. Cell 2013;153(6):1194-1217. doi: 10.1016/j.cell.2013.05.039

Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell 2014;159(4):709-13. doi: 10.1016/j.cell.2014.10.039

Li G, Fan Y, Lai Y, Han T, Li Z, Zhou P, et al. Coronavirus infections and immune responses. J Med Virol 2020; 92(4):424-32. doi: 10.1002/jmv.25685

Cunha L, Perazzio S, Azzi J, Cravedi P, Riella L. Remodeling of the immune response with aging: immunosenescence and its potential impact on COVID-19 immune response. Front Immunol 2020;11:1748. doi: 10.3389/fimmu.2020.01748

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5

Callender LA, Curran M, Bates SM, Mairesse M, Weigandt J, Betts CJ. The impact of pre-existing comorbidities and therapeutic interventions on COVID-19. Front Immunol 2020;11:1991. doi: 10.3389/fimmu.2020.01991

Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease study 2013. Lancet 2015;386(9995):743-800. doi: 10.1016/S0140-6736(15)60692-4

Word Health Organization (WHO). COVID-19 and NCDs: Preliminary results: rapid assessment of service delivery for noncommunicable diseases during the COVID-19 pandemic [Internet]. WHO 2020 May 29 [cited 2021 Mar 3]. Available from: https://reliefweb.int/report/world/covid-19-and-ncds-preliminary-results-rapid-assessment-service-delivery-noncommunicable

Olloquequi J. COVID-19 susceptibility in chronic obstructive pulmonary disease. Eur J Clin Invest 2020;50:1-8. doi: 10.1111/eci.13382

Leão L, Ferreira V, Faustino A. O idoso e a pandemia do COVID-19: uma análise de artigos em jornais. Braz J Dev 2020;6(7):45123-42. https://doi.org/10.34117/bjdv6n7-218

Downloads

Arquivos adicionais

Publicado

2022-02-11